Global Protein Production Market Overview:
Protein production is a biotechnological process for obtaining new enhanced specific targeted protein that will help in the prevention and cure of various diseases. It is commonly achieved by the modifying of gene expression in an organism such that it expresses large amounts of a recombinant gene. It can be done in different media of prokaryotic eukaryotic, insect cell, free cells, etc. Protein production can be done by following a basic process, it occurs in two stages: transcription and translation. Transcription is used for the transfer of genetic instructions in DNA to mRNA in the nucleus. This majorly includes three steps: initiation, elongation, and termination.
Attributes | Details |
---|
Study Period | 2017-2027 |
Base Year | 2021 |
Forecast Period | 2022-2027 |
Historical Period | 2017-2021 |
Unit | Value (USD Million) |
Customization Scope | Avail customization with purchase of this report. Add or modify country, region & or narrow down segments in the final scope subject to feasibility |
Protein Production Market Dynamics:
Attributes | Details |
---|
Growth Drivers | - Low Cost Associated With Production
- High Protein Yield
- Growing Demand as it Gives Highly Purified Protein
|
Restraints | - Eukaryotic Co and Post Translation Al Modification Not Possible
|
Road Blocks / Challenges | - Long Research and Development Studies Required
|
Gaps & Opportunities | - Highly Demanded as it is Used in Various Incurable Diseases
- Growing Use in Various Research Studies and Clinical Trials
|
Competitive Landscape:
The new drug discoveries are on the verge of different diseases cure and prevention, protein production is used for different drug discovery which is increasing the reputation of various companies in the market. These new drug discoveries using protein production only possible if there is the availability of high technical knowledge professionals in the team. There is high competition between top leading firms to acquire the market through new innovative and useful discoveries. Also, by trying mergers and acquisitions to be strong in the market by every aspect.
Some of the key players profiled in the report are Thermo Fisher Scientific (United States), New England Biolabs (United States), Lonza Group (Switzerland), Polyphor (Switzerland), Idorsia Pharmaceuticals Ltd (Switzerland), Santhera Pharmaceuticals (Switzerland), Nabriva Therapeutics (Ireland), Bio-Synthesis Inc (United States), Sigma-Aldrich (United States) and GenScript Biotech (United States). Additionally, following companies can also be profiled that are part of our coverage like ATUM (United States), Promega (United States), Biosearch Technologies (United States) and Bitesize Bio (Scotland). Analyst at AMA Research see United States Players to retain maximum share of Global Protein Production market by 2027. Considering Market by Services, the sub-segment i.e. Reagents will boost the Protein Production market. Considering Market by End Users, the sub-segment i.e. Pharmaceutical and Biotechnology Companies will boost the Protein Production market. Considering Market by Disease , the sub-segment i.e. Diabetes will boost the Protein Production market.
Latest Market Insights:
On 13th February 2020 Thermo Fisher Scientific, the world leader in serving science, and NanoPin Technologies, Inc., the developer of the novel NanoPin diagnostic platform for rapid and quantified results from patient blood samples, have entered into a collaborative relationship to advance blood-based infectious disease detection technology through the development of highly sensitive liquid chromatography-mass spectrometry (LC-MS)-based workflows.
On 5th February 2020 Thermo Fisher Scientific introduced a new next-generation sequencing (NGS)-based solution that enables reproductive health researchers to more efficiently analyze a broad range of key genetic markers with an end-to-end workflow. TheIon Torrent carrier SeqECS for the Ion GeneStudio S5 System consolidates a multi-platform approach to expanded carrier screening (ECS) into a single solution that extends the company's reproductive health research portfolio, which includes tools for prenatal, postnatal, in-vitro fertilization and newborn screening analysis.
U.S. Department of Health and Human Services Food and Drug Administration Center for Drug Evaluation and Research (CDER) Centre for Biologics Evaluation and Research (CBER) regulates following guidance describes procedures for the early food safety evaluation of new non-pesticidal proteins produced by such new plant varieties, including for example such proteins produced in bioengineered plants. FDA's guidance documents, including this guidance, do not establish legally enforceable responsibilities. Test Procedures and Acceptance Criteria for Biotechnological/Biological Products the guidance represents the Food and Drug Administration's (FDA's) current thinking on this topic.
What Can be Explored with the Protein Production Market Study
Gain Market Understanding
Identify Growth Opportunities
Analyze and Measure the Global Protein Production Market by Identifying Investment across various Industry Verticals
Understand the Trends that will drive Future Changes in Protein Production
Understand the Competitive Scenario
- Track Right Markets
- Identify the Right Verticals
Research Methodology:
The top-down and bottom-up approaches are used to estimate and validate the size of the Global Protein Production market.
In order to reach an exhaustive list of functional and relevant players various industry classification standards are closely followed such as NAICS, ICB, SIC to penetrate deep in important geographies by players and a thorough validation test is conducted to reach most relevant players for survey in Protein Production market.
In order to make priority list sorting is done based on revenue generated based on latest reporting with the help of paid databases such as Factiva, Bloomberg etc.
Finally the questionnaire is set and specifically designed to address all the necessities for primary data collection after getting prior appointment by targeting key target audience that includes Protein products manufacturers, Protein instruments manufacturers, Distributors/suppliers, Various research and consulting companies, Research laboratories and research institutes and Universities and CROs.
This helps us to gather the data related to players revenue, operating cycle and expense, profit along with product or service growth etc.
Almost 70-80% of data is collected through primary medium and further validation is done through various secondary sources that includes Regulators, World Bank, Association, Company Website, SEC filings, OTC BB, USPTO, EPO, Annual reports, press releases etc.